Thomas et al. [31] demonstrated that cardiomyocyte-specific NF-κB signaling inhibition could attenuate diabetes-induced cardiac dysfunction through the suppression of the cardiac renin-angiotensin system. The gene discussed is NFKB1; the disease is diabetes mellitus.